$744.7 M

ANGO Mkt cap, 11-Oct-2018

$85.3 M

AngioDynamics Revenue Q1, 2019
AngioDynamics Gross profit (Q1, 2019)44.5 M
AngioDynamics Gross profit margin (Q1, 2019), %52.1%
AngioDynamics Net income (Q1, 2019)-469 K
AngioDynamics EBIT (Q1, 2019)326 K
AngioDynamics Cash, 31-Aug-201824.8 M
AngioDynamics EV810.3 M

AngioDynamics Revenue

AngioDynamics revenue was $344.29 m in FY, 2018

Embed Graph

AngioDynamics Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

354.5m357.0m353.9m344.3m

Revenue growth, %

1%(1%)

Cost of goods sold

174.6m180.1m179.6m167.4m

Gross profit

179.9m176.9m174.3m176.9m

Gross profit Margin, %

51%50%49%51%

Sales and marketing expense

84.7m77.3m

R&D expense

25.1m25.5m

General and administrative expense

29.6m31.3m

Operating expense total

139.4m166.3m

Depreciation and amortization

16.6m

EBIT

13.4m(994.0k)1.0m10.6m

EBIT margin, %

4%0%0%3%

Interest expense

3.7m3.2m3.4m3.1m

Interest income

4.0k11.0k

Pre tax profit

7.5m

Income tax expense

3.3m(4.7m)40.3m(8.9m)

Net Income

3.1m(3.3m)(43.6m)16.3m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2018Q1, 2019

Revenue

83.7m89.2m87.4m86.7m85.3m

Cost of goods sold

40.5m43.4m43.9m44.0m40.9m

Gross profit

43.2m45.8m43.5m42.7m44.5m

Gross profit Margin, %

52%51%50%49%52%

Sales and marketing expense

20.6m20.6m20.3m19.0m19.4m

R&D expense

6.2m6.2m5.8m6.1m7.7m

General and administrative expense

7.4m8.1m6.8m7.5m8.5m

Operating expense total

42.1m44.5m40.8m41.6m44.1m

Depreciation and amortization

4.1m4.1m

EBIT

1.1m1.3m2.7m1.1m326.0k

EBIT margin, %

1%1%3%1%0%

Interest expense

800.0k998.0k809.0k760.0k917.0k

Interest income

1.0k1.0k2.0k

Pre tax profit

83.0k(477.0k)

Income tax expense

83.0k(366.0k)382.0k(166.0k)(8.0k)

Net Income

(426.0k)(99.0k)5.1m470.0k1.3m(4.3m)(757.0k)(362.0k)630.0k249.0k(469.0k)

AngioDynamics Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Cash

16.1m18.4m32.3m74.1m

Accounts Receivable

Inventories

61.1m67.4m55.4m48.9m

Current Assets

152.2m155.8m146.3m168.0m

PP&E

67.2m54.6m48.3m42.5m

Goodwill

360.3m361.3m361.3m361.3m

Total Assets

800.2m773.6m727.1m705.5m

Accounts Payable

32.9m23.7m15.6m15.8m

Short-term debt

5.0m8.8m16.3m5.0m

Current Liabilities

72.3m61.2m66.7m57.3m

Long-term debt

128.9m105.2m86.6m

Total Debt

137.7m121.4m91.6m

Total Liabilities

219.8m162.9m

Additional Paid-in Capital

508.3m520.1m525.8m543.8m

Retained Earnings

32.7m28.2m(16.0m)5.1m

Total Equity

545.0m507.2m542.6m

Debt to Equity Ratio

0.3 x0.2 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.4 x1.4 x1.3 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2018Q1, 2019

Cash

22.1m15.2m7.4m13.8m14.9m19.7m20.3m19.0m21.9m49.9m24.8m

Inventories

59.2m60.1m59.8m70.4m75.3m68.7m74.3m70.8m65.8m54.0m49.7m

Current Assets

145.2m141.6m140.1m154.3m163.4m157.3m160.0m151.6m149.4m152.5m120.9m

PP&E

51.2m49.7m43.8m42.2m

Goodwill

359.7m359.7m359.7m360.5m360.5m360.5m361.3m361.3m361.3m361.3m383.0m

Total Assets

801.2m795.5m792.2m796.1m799.3m783.1m771.8m760.4m753.5m697.8m693.9m

Accounts Payable

26.7m28.3m25.5m29.3m22.0m21.7m24.9m21.7m18.1m21.8m16.9m

Short-term debt

13.1m5.0m5.0m5.0m6.3m7.5m10.0m11.3m12.5m5.0m5.0m

Current Liabilities

74.4m69.1m63.4m63.7m57.9m59.7m60.7m60.1m61.6m59.7m45.8m

Long-term debt

129.4m141.4m126.4m122.7m113.9m89.0m85.4m

Total Debt

142.5m5.0m5.0m5.0m6.3m148.9m136.4m133.9m126.4m94.0m90.4m

Total Liabilities

272.7m265.8m254.5m256.4m255.8m239.4m224.7m212.7m202.8m176.6m149.0m

Additional Paid-in Capital

502.3m504.0m506.6m510.7m513.4m518.3m523.0m524.2m526.5m538.4m546.6m

Retained Earnings

29.1m29.0m34.1m32.0m33.3m29.0m27.5m27.1m27.7m(11.0m)4.7m

Total Equity

528.4m529.7m537.7m547.1m547.6m550.7m521.2m544.9m

Financial Leverage

1.5 x1.5 x1.5 x1.4 x1.4 x1.4 x1.3 x1.3 x

AngioDynamics Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Net Income

3.1m(3.3m)(43.6m)16.3m

Depreciation and Amortization

16.8m17.9m18.0m23.2m

Accounts Receivable

(15.0m)2.1m3.1m5.0m

Inventories

(5.4m)(6.2m)12.0m5.7m

Accounts Payable

Cash From Operating Activities

25.3m26.2m45.2m41.3m

Purchases of PP&E

(11.8m)(11.9m)(2.3m)(2.4m)

Cash From Investing Activities

(17.0m)(13.3m)(7.6m)(3.7m)

Long-term Borrowings

(146.2m)(20.0m)(16.2m)(5.0m)

Cash From Financing Activities

(14.0m)(10.5m)(23.7m)(11.6m)

Interest Paid

3.6m3.2m3.1m3.2m

Income Taxes Paid

182.0k699.0k332.0k36.0k

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2019

Net Income

(426.0k)(525.0k)4.6m470.0k1.8m(2.5m)(757.0k)(1.1m)(489.0k)(469.0k)

Depreciation and Amortization

6.1m12.3m18.8m6.7m14.0m22.8m7.2m14.4m21.4m5.6m

Accounts Receivable

1.9m(103.0k)(9.7m)5.8m3.1m3.5m5.9m4.9m2.5m(562.0k)

Inventories

(3.5m)(4.4m)(4.2m)(9.2m)(14.1m)(7.5m)(6.9m)(3.5m)1.5m(761.0k)

Cash From Operating Activities

7.3m15.8m15.2m5.4m3.2m15.4m4.7m14.3m26.7m(8.9m)

Purchases of PP&E

(2.9m)(7.2m)(9.0m)(5.1m)(7.5m)(11.0m)(743.0k)(1.2m)(1.9m)(682.0k)

Cash From Investing Activities

(6.8m)(11.2m)(13.0m)(5.3m)(7.8m)(12.0m)(743.0k)(1.1m)(3.9m)(37.7m)

Long-term Borrowings

(1.9m)(143.7m)(145.0m)(1.2m)(2.5m)(8.7m)(1.2m)(3.7m)(11.2m)(1.2m)

Cash From Financing Activities

(272.0k)(11.2m)(16.7m)(2.4m)3.4m641.0k(2.1m)(12.4m)(19.2m)(2.6m)

AngioDynamics Ratios

USDY, 2018

EV/EBIT

2.5 k x

EV/CFO

-91.3 x

Financial Leverage

1.3 x
Report incorrect company information